Sign Up to like & get
recommendations!
0
Published in 2021 at "Drug testing and analysis"
DOI: 10.1002/dta.3172
Abstract: IOX4 is a hypoxia-inducible factor prolyl hydroxylase (HIF-PHD) inhibitor, which was developed for the treatment of anemia by exerting hematopoietic effects. The administration of HIF-PHD inhibitors such as IOX4 to horses is strictly prohibited by…
read more here.
Keywords:
plasma;
urine plasma;
metabolic study;
comprehensive metabolic ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Medical Care"
DOI: 10.1097/mlr.0000000000001816
Abstract: Aims: We evaluated the impact of reimbursement for non–face-to-face chronic care management (NFFCCM) on comprehensive metabolic risk factors among multimorbid Medicare beneficiaries with type 2 diabetes in Louisiana. Materials and Methods: We implemented a propensity…
read more here.
Keywords:
comprehensive metabolic;
face;
impact reimbursement;
care ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/0008-5472.can-22-3000
Abstract: Stable isotope 13C1-serine and 13C6-cystine tracing characterizes cysteine metabolism in normal murine tissues and its rewiring in tumors using genetically engineered mouse models of liver, pancreas, and lung cancers.
read more here.
Keywords:
comprehensive metabolic;
catabolism cysteine;
reveals origin;
origin catabolism ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14051311
Abstract: Simple Summary The oncogene MYC alters cellular metabolism. Medulloblastoma is the most common malignant pediatric brain tumor. MYC-amplified medulloblastoma has a poor prognosis, and the metabolism of MYC-amplified medulloblastoma is poorly understood. We performed comprehensive…
read more here.
Keywords:
myc amplified;
comprehensive metabolic;
brain;
myc ... See more keywords